- Published at
- by seekingalpha.com
mixed
mixed
News for Ionis Pharmaceuticals, Inc. (IONS)
- Published at
- by benzinga.com
mixedmixedThis Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Ionis Pharmaceuticals (NASDAQ:IONS), Axsome Therapeutics (NASDAQ:AXSM)
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...- Published at
- by seekingalpha.com
positivepositiveBiogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status
Biogen's Alzheimer’s therapy BIIB080 gains FDA Fast Track status, expediting its development. Read more here.- Published at
- by manilatimes.net
positivepositive- Published at
- by financialpost.com
mixedmixedBiogen's Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer's Disease
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) —- Published at
- by gurufocus.com
positivepositiveBB Biotech AG Reduces Stake in Black Diamond Therapeutics Inc
On March 19, 2025, BB Biotech AG made a significant move by reducing its position in Black Diamond Therapeutics Inc (NASDAQ: BDTX). The firm sold 5,784,292 shar- Published at
- by zacks.com
neutralneutralWhy Is Ionis Pharmaceuticals (IONS) Up 0.1% Since Last Earnings Report?
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.- Published at
- by gurufocus.com
positivepositiveBB Biotech AG Reduces Stake in Esperion Therapeutics Inc
On March 4, 2025, BB Biotech AG executed a strategic transaction involving Esperion Therapeutics Inc. The firm reduced its holdings by 250,000 shares at a trade- Published at
- by gurufocus.com
positivepositiveIonis and Ono announce global license agreement for sapablursen in polycythemia vera
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have entered into a licen- Published at
- by gurufocus.com
positivepositive- Published at
- by investing.com
positivepositiveLattice Semi: Investors Who Missed This Sell Signal Are Now Counting a 37% Loss
Stocks Analysis by Investing.com (Chinmay Pandya) covering: Ionis Pharmaceuticals Inc, Lattice Semiconductor Corporation, Manchester United Ltd, Five Below Inc. Read Investing.com (Chinmay Pandya)'s latest article on Investing.com- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveDecoding Avidity Biosciences Inc (RNA): A Strategic SWOT Insight
Strengths: Innovative AOC platform and robust pipeline with potential for significant market impact.Weaknesses: Lack of commercialization experience and high R- Published at
- by gurufocus.com
positivepositiveTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
Achieved record positive Adjusted EBITDA* of $20 million for FY2024 (net loss of $8.3 million), exceeding latest guidance of $17-19 million Achieved record qua- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveIonis Pharmaceuticals Inc (IONS) Announces Participation in Upcoming Investor Conferences
Ionis Pharmaceuticals Inc (IONS) has announced its management team will participate in a series of fireside chats at several prestigious investor conferences in- Published at
- by gurufocus.com
positivepositiveIonis to present at upcoming investor conferences
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Raymond- Published at
- by insidermonkey.com
neutralneutralWhy Ionis Pharmaceuticals (IONS) Is Among the Most Oversold Healthcare Stocks to Buy Now
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Ionis Pharmaceuticals, Inc.- Published at
- by seekingalpha.com
neutralneutralIonis Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:IONS)
The following slide deck was published by Ionis Pharmaceuticals, Inc.- Published at
- by zacks.com
neutralneutralIonis Pharmaceuticals (IONS) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Ionis Pharmaceuticals (IONS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.